Effectiveness and safety of vedolizumab in a matched cohort of elderly and young Inflammatory Bowel Disease patients - LIVE Study-Group

被引：0
|
作者：
Pugliese, D. [1 ]
Privitera, G. [2 ]
Armuzzi, A. [3 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, CEMAD IBD UNIT, Unita Operat Complessa Med Interna & Gastroentero, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Rome, Italy
[3] Univ Cattolica, Fdn Policlin Univ Agostino Gemelli IRCCS, CEMAD IBD Unit, Unita Operat Complessa Med Interna & Gastroentero, Rome, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab073.088
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP49
引用
收藏
页码：S085 / S085
页数：1
相关论文
共 50 条
  • [11] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [12] Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study
    Wils, Pauline
    Seksik, Philippe
    Stefanescu, Carmen
    Nancey, Stephane
    Allez, Matthieu
    de Chambrun, Guillaume Pineton
    Altwegg, Romain
    Gilletta, Cyrielle
    Vuitton, Lucine
    Viennot, Stephanie
    Serrero, Melanie
    Fumery, Mathurin
    Savoye, Guillaume
    Collins, Michael
    Goutorbe, Felix
    Brixi, Hedia
    Bouguen, Guillaume
    Tavernier, Noemie
    Boualit, Medina
    Amiot, Aurelien
    Abitbol, Vered
    Laharie, David
    Pariente, Benjamin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (04) : 460 - 470
  • [13] A MULTICENTER COHORT STUDY TO ASSESS THE SAFETY OF VEDOLIZUMAB FOR INFLAMMATORY BOWEL DISEASE
    Meserve, Joseph
    Aniwan, Satimai
    Koliani-Pace, Jenna
    Shashi, Preeti
    Weiss, Aaron
    Faleck, David
    Winters, Adam
    Chablaney, Shreya
    Kochhar, Gursimran
    Boland, Brigid S.
    Singh, Siddharth
    Hirten, Robert
    Shmidt, Eugenia
    Bohm, Matthew
    Sagi, Sashivar
    Fischer, Monika
    Lukin, Dana J.
    Hudesman, David
    Chang, Shannon
    Keith, Sultan
    Swaminath, Arun
    Gupta, Nitin
    Kane, Sunanda V.
    Loftus, Edward V.
    Shen, Bo
    Sands, Bruce E.
    Colombel, Jean Frederic
    Siegel, Corey A.
    Sandborn, William J.
    Dulai, Parambir
    GASTROENTEROLOGY, 2018, 154 (06) : S361 - S361
  • [14] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [15] A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
    Meserve, J.
    Aniwan, S.
    Koliani-Pace, J. L.
    Shashi, P.
    Weiss, A.
    Faleck, D.
    Winters, A.
    Chablaney, S.
    Kochhar, G.
    Boland, B.
    Singh, S.
    Hirten, R.
    Shmidt, E.
    Bohm, M.
    Sagi, S. V.
    Fischer, M.
    Lukin, D.
    Hudesman, D.
    Chang, S.
    Sultan, K.
    Swaminath, A.
    Gupta, N.
    Kane, S.
    Loftus, E. V.
    Shen, B.
    Sands, B. E.
    Colombel, J. -F.
    Siegel, C. A.
    Sandborn, W. J.
    Dulai, P. S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S34 - S34
  • [16] Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
    Garcia-Romero, Ruth
    Martinez de Zabarte Fernandez, Jose Miguel
    Pujol-Muncunill, Gemma
    Donat-Aliaga, Ester
    Segarra-Canton, Oscar
    Irastorza-Terradillos, Inaki
    Medina-Benitez, Enrique
    Ruiz-Hernandez, Carlos Jose
    Carrillo-Palau, Marta
    Ros-Arnal, Ignacio
    Rodriguez-Martinez, Alejandro
    Escartin-Madurga, Laura
    Gutierrez-Junquera, Carolina
    Vicente-Santamaria, Saioa
    Velasco Rodriguez-Belvis, Marta
    Fernandez-Fernandez, Sonia
    Alberto-Alonso, Jose Ramon
    Montraveta, Montserrat
    Torres-Peral, Ricardo
    Navalon-Rubio, Maria
    Navas-Lopez, Victor Manuel
    Martin de Carpi, Javier
    EUROPEAN JOURNAL OF PEDIATRICS, 2021, 180 (09) : 3029 - 3038
  • [17] Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
    Ruth Garcia-Romero
    José Miguel Martinez de Zabarte Fernandez
    Gemma Pujol-Muncunill
    Ester Donat-Aliaga
    Oscar Segarra-Cantón
    Iñaki Irastorza-Terradillos
    Enrique Medina-Benitez
    Carlos José Ruiz-Hernández
    Marta Carrillo-Palau
    Ignacio Ros-Arnal
    Alejandro Rodriguez-Martínez
    Laura Escartin-Madurga
    Carolina Gutiérrez-Junquera
    Saioa Vicente-Santamaría
    Marta Velasco Rodriguez-Belvis
    Sonia Fernández-Fernández
    José Ramón Alberto-Alonso
    Montserrat Montraveta
    Ricardo Torres-Peral
    María Navalon-Rubio
    Víctor Manuel Navas-López
    Javier Martin de Carpi
    European Journal of Pediatrics, 2021, 180 : 3029 - 3038
  • [18] Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study
    Burgevin, Alice
    Caron, Benedicte
    Sasson, Alexa
    Luc, Amandine
    Netter, Patrick
    Baumann, Cedric
    Ananthakrishnan, Ashwin N.
    Peyrin-Biroulet, Laurent
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [19] Effectiveness and safety of vedolizumab for the induction of remission in inflammatory bowel disease
    Chaparro, M.
    Sierra-Ausin, M.
    Mesonero, F.
    Maroto, N.
    Fernandez de Castro, C.
    Garcia-Sanchez, V.
    Lucendo, A. J.
    Busquets, D.
    Barreiro-de Acosta, M.
    Marin-Jimenez, I.
    Beltran, B.
    Ruiz Belmonte, L.
    Bermejo, F.
    Minguez, M.
    Pajares, R.
    Pineda, J. R.
    Sicilia, B.
    Martin-Rodriguez, D.
    Gutierrez, A.
    Rubio, S.
    Garcia Tercero, I.
    Piqueras, M.
    Ginard, D.
    Jucha, B.
    Munoz Villafranca, C.
    Martin-Arranz, M. D.
    Marti Romero, L.
    Fernandez Bonilla, E. M.
    Echarri, A.
    Forcelledo, J. F.
    Donday, M. G.
    Ramas, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S416 - S417
  • [20] One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study
    Amiot, A.
    Serrero, M.
    Peyrin-Biroulet, L.
    Filippi, J.
    Pariente, B.
    Roblin, X.
    Buisson, A.
    Stefanescu, C.
    Trang-Poisson, C.
    Altwegg, R.
    Marteau, P.
    Vaysse, T.
    Bourrier, A.
    Nancey, S.
    Laharie, D.
    Allez, M.
    Savoye, G.
    Moreau, J.
    Vuitton, L.
    Viennot, S.
    Aubourg, A.
    Pelletier, A. -L.
    Bouguen, G.
    Abitbol, V.
    Gagniere, C.
    Bouhnik, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (03) : 310 - 321
12345